New York Post Highlights Contrast Therapy Benefits with Expert Insight from Dr. Quay

You might have heard about contrast therapy—the practice of alternating heat and cold to boost your health. It’s trending now, but it’s actually been around for centuries. The New York Post recently tapped Dr. Quay for his expert insight on why this ancient technique still matters today.

Here’s why contrast therapy works, according to Dr. Quay:

How to try contrast therapy at home:

No sauna or ice plunge? No worries. Dr. Quay suggests this easy at-home method:

A note on safety:

Contrast therapy is generally safe, but it’s not for everyone. If you’re pregnant, have cardiovascular disease, high blood pressure, epilepsy, or other serious health conditions, consult your doctor first. Avoid doing contrast therapy if you’ve consumed alcohol or drugs.

Steven Quay is the founder of Seattle-based Atossa Therapeutics Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other breast conditions.

He received his M.D. and Ph.D. from The University of Michigan, was a postdoctoral fellow at MIT with Nobel Laureate H. Gobind Khorana, a resident at the Harvard-MGH Hospital, and was on the faculty of Stanford University School of Medicine. His contributions to medicine have been cited over 9,600 times. He has founded six startups, invented seven FDA-approved pharmaceuticals, and holds 87 US patents. Over 80 million people have benefited from the medicines he invented.

His current passion is the prevention of the two million yearly breast cancer cases worldwide.

Related Content

Watch Dr. Steven Quay’s interview on America at Night as he discusses genetic privacy, public health reform, and the ethics of gain-of-function research. Learn more and preorder Dr. Quay’s new book, The Code as Witness.

Dr. Steven Quay joins Real America’s Voice to explore whether President Biden’s public health changes could reflect the side effects of prostate cancer treatment. Learn how early detection and treatment can affect cognitive and physical health, and why these questions matter for both patients and national leaders.